Neurexins are essential presynaptic cell adhesion molecules that are linked to schizophrenia and autism and are subject to extensive alternative splicing. Here, we used a genetic approach to test the physiological significance of neurexin alternative splicing. We generated knockin mice in which alternatively spliced sequence #4 (SS4) of neuexin-3 is constitutively included but can be selectively excised by cre-recombination. SS4 of neurexin-3 was chosen because it is highly regulated and controls neurexin binding to neuroligins, LRRTMs, and other ligands. Unexpectedly, constitutive inclusion of SS4 in presynaptic neurexin-3 decreased postsynaptic AMPA, but not NMDA receptor levels, and enhanced postsynaptic AMPA receptor endocytosis. Moreover, constitutive inclusion of SS4 in presynaptic neurexin-3 abrogated postsynaptic AMPA receptor recruitment during NMDA receptor-dependent LTP. These phenotypes were fully rescued by constitutive excision of SS4 in neurexin-3. Thus, alternative splicing of presynaptic neurexin-3 controls postsynaptic AMPA receptor trafficking, revealing an unanticipated alternative splicing mechanism for trans-synaptic regulation of synaptic strength and long-term plasticity.
INTRODUCTION
Central synapses exhibit a large diversity in properties, such as presynaptic release probability, postsynaptic receptor composition, and long-term plasticity. In a given neuron, these properties depend on both the pre-and the postsynaptic neuron (Reyes et al., 1998; Koester and Johnston, 2005) . Trans-synaptic cell adhesion molecules not only organize and synchronize assembly of synapses, but also likely determine their properties and diversity. Neurexins are trans-synaptic cell adhesion molecules that are candidate molecules for mediating trans-synaptic specification of synaptic properties (Craig and Kang, 2007; Sü dhof, 2008; Krueger et al., 2012) .
Neurexins are expressed as a-and b-neurexins from independent promoters in three genes (Ushkaryov et al., 1992 (Ushkaryov et al., , 1994 Ushkaryov and Sü dhof, 1993; Tabuchi and Sü dhof, 2002; Rowen et al., 2002) . The larger a-neurexins are composed of six LNS domains with three interspersed EGF-like domains followed by a transmembrane region and a short cytoplasmic tail. The smaller b-neurexins lack the N-terminal five LNS and three EGF-like domains of a-neurexins but instead contain a unique short N-terminal sequence. b-neurexins splice into the 6 th LNS domain of a-neurexins and are identical with a-neurexins in all C-terminal sequences. The six principal neurexins (Nrx1a-3a and Nrx1b-3b) are expressed in differential but overlapping patterns in all neurons, such that most neurons synthesize multiple a-and b-neurexins in different combinations . In mice, triple knockout (KO) of Nrx1a, Nrx2a, and Nrx3a is lethal despite continued expression of Nrx1b, Nrx2b, and Nrx3b (Missler et al., 2003) . a-neurexin triple KO mice die because of a severe impairment in synaptic transmission. Neurexins are assumed to be presynaptic because they act as a-latrotoxin receptors (Ushkaryov et al., 1992; Sugita et al., 1999) and because the a-neurexin triple KO phenotype suggested a presynaptic function (Missler et al., 2003) . However, triple a-neurexin KO mice also displayed a postsynaptic phenotype (Kattenstroth et al., 2004) , and recent studies in Drosophila and C. elegans proposed a postsynaptic localization for neurexins (Chen et al., 2012; Hu et al., 2012) . The latter results are consistent with at least some (Taniguchi et al., 2007) but not all immunolocalization data (Ushkaryov et al., 1992) , making it uncertain whether neurexins act pre-or postsynaptically.
Mutations in the human Nrx1 (NRXN1) and Nrx2 (NRXN2) gene have been associated with diverse neuropsychiatric disorders, especially autism and schizophrenia (reviewed in Sü dhof, 2008; Reichelt et al., 2012) . Changes in the human Nrx3 gene (NRXN3) have also been associated with autism (Vaags et al., 2012) Ullrich et al., 1995) . SS1, SS2, and SS3 are specific to a-neurexins, whereas SS4 and SS5 are present in both a-and b-neurexins. Neurexin alternative splicing is highly regulated. In particular, neurexin SS4 splice variants are differentially expressed in various brain regions , exhibit a diurnal cycle (Shapiro-Reznik et al., 2012) , and are modulated by neuronal activity (Resnick et al., 2008; Iijima et al., 2011; Rozic et al., 2012) . These data suggest that neurexin alternative splicing may be physiologically important, but its biological significance has not been tested.
Neurexins bind to multiple postsynaptic cell adhesion molecules, including neuroligins (Ichtchenko et al., 1995) , dystroglycan (Sugita et al., 2001) , LRRTMs (Ko et al., 2009; de Wit et al., 2009; Siddiqui et al., 2010) , GluRd2 via cerebellins (Uemura et al., 2010) , and CIRL/latrophilin (Boucard et al., 2012) . Binding of these ligands is modulated by neurexin alternative splicing at SS4. SS4 exists in two forms that include (SS4+) or exclude (SS4-) an alternatively spliced exon encoding 30 residues. Strikingly, only SS4-neurexins bind to dystroglycan, CIRL/latrophilin, and LRRTMs (Boucard et al., 2012; Ko et al., 2009; Siddiqui et al., 2010; Sugita et al., 2001) , whereas only SS4+ neurexins bind to cerebellins (Matsuda and Yuzaki, 2011; Uemura et al., 2010) . Moreover, SS4-and SS4+ neurexins exhibit distinct affinities for different isoforms of neuroligins, creating a ''splice code'' of interactions (Boucard et al., 2005; Chih et al., 2006; Comoletti et al., 2006) . However, despite the known effect of SS4 alternative splicing on neurexin-ligand interactions and its mechanistic understanding, it is unclear whether SS4 alternative splicing is physiologically important. No approaches are available to directly test the significance of alternative splicing for molecules such as neurexins, which are alternatively processed at multiple positions and whose overexpression in itself may produce biological effects. Apart from the fact that no KOs targeting both a-and b-neurexins are available, such studies are made difficult because rescue experiments cannot test all splice combinations at physiological expression levels.
Here, we apply a genetic knockin approach to test the biological significance of neurexin alternative splicing at SS4. Using homologous recombination, we changed the splice-acceptor sequence of the alternatively spliced SS4 exon, thereby converting it into a constitutively included exon that is no longer subject to alternative splicing. At the same time, we rendered the SS4 exon conditional by floxing it. Thus, we here describe a genetic approach that allows conditional control of alternative splicing of neurexins and may be generally applicable to vertebrate genes. Using this approach, we found that constitutive expression of Nrx3-SS4+ produced a selective alteration in postsynaptic AMPA-receptor (AMPAR), but not NMDA-receptor (NMDAR) trafficking, such that postsynaptic AMPAR levels were lowered, synaptic strength was decreased, and NMDAR-dependent LTP was attenuated. These phenotypes were fully reversed by cre-dependent excision of the SS4 exon. Moreover, we found that the effect of SS4 alternative splicing was not mediated by a cell-autonomous postsynaptic effect but, rather, by a trans-synaptic noncell-autonomous action of presynaptic Nrx3 on postsynaptic neurons and that constitutive expression of Nrx3-SS4+ causes a loss of the postsynaptic neurexin ligand LRRTM2. These results provide a direct test of the physiological function of neurexin alternative splicing in vivo that was not possible with a nongenetic approach and demonstrate an unanticipated mechanism by which alternative splicing of a neurexin in a presynaptic neuron trans-synaptically controls postsynaptic properties.
RESULTS

Region-Specific Alternative Splicing of Nrx3 at SS4
Although qualitative studies showed that alternative splicing of neurexins at SS4 is highly regulated , no quantitative assessment of neurexin alternative splicing is available. Thus, we developed quantitative reverse-transcriptase PCR (qRT-PCR) assays for the alternatively spliced versions of SS4 for Nrx1, Nrx2, and Nrx3 ( Figure S1 available online) and measured their messenger RNA (mRNA) levels in various brain regions from adult mice ( Figure 1A) .
We found that the three neurexin genes were expressed at comparable levels in different brain regions and exhibited a coordinate but differential pattern of SS4 alternative splicing ( Figure 1A ). Some brain regions (e.g., striatum and cerebellum) expressed primarily ($90%) SS4+ forms of all three neurexins. Other brain regions (e.g., cortex and hippocampus) expressed similar amounts of SS4+ and SS4-forms of Nrx1 and Nrx2 but Figure S1 .
primarily the SS4-form of Nrx3 ($90%; Figure 1A ). Thus, alternative splicing of neurexins at SS4 is regionally regulated, with the largest differential in expression observed for Nrx3, prompting us to focus on this isoform.
Conditional Mutant Mice in Which SS4 Alternative Splicing of Nrx3 Is Blocked To test the role of SS4 alternative splicing of Nrx3, we sought to develop a new genetic approach. We noted that the alternatively spliced SS4 exon in the mouse Nrxn3 gene (exon 20; Tabuchi and Sü dhof, 2002) contains an unusual purinerich splice acceptor sequence ( Figure 1B ). Using homologous recombination in mouse embryonic stem cells, we converted this imperfect splice acceptor sequence into a canonical consensus sequence ( Figure 1B ). We also introduced flanking loxP sites, such that exon 20 could be conditionally deleted. Using this strategy, we obtained mutant mice that were designed to constitutively insert the normally alternatively spliced SS4 sequence into all Nrx3 mRNAs, thus rendering all Nrx3 mRNAs SS4+ (referred to as Nrx3 SS4+ genotype). At the same time, these mutant mice allow exclusion of the SS4 sequence after cre-recombinase-mediated deletion of exon 20, rendering all Nrx3 mRNAs SS4-(referred to as Nrx3 genotype; Figure 1B Figure 1C ). Total Nrx3 mRNA levels were not significantly altered by either manipulation. Thus, we generated mutant mice in which neurons produce only Nrx3-SS4+ mRNAs but can be converted by cre-recombination to produce only Nrx3-SS4-mRNAs.
Blocking SS4 Alternative Splicing of Nrx3 Alters AMPAR-Mediated Responses
Electrophysiological recordings revealed that spontaneous miniature excitatory postsynaptic currents (mEPSCs) exhibited a significantly lower amplitude in Nrx3 SS4+ than in WT or Nrx3
SS4À
neurons but displayed no change in frequency ( Figures 1D, 1E , and S1C). Neither the amplitude nor the frequency of spontaneous miniature inhibitory postsynaptic currents (mIPSCs) was altered ( Figures 1D, 1F , and S1E). The mEPSC or mIPSC rise or decay kinetics and intrinsic properties of the neurons were unchanged (Figures S1D and S1F). Neurexins are thought to be presynaptic, whereas changes in the mEPSC amplitude generally reflect postsynaptic changes. Thus, these findings were surprising and suggested that alternative splicing of presynaptic Nrx3 may alter excitatory synaptic strength by a postsynaptic mechanism.
We next measured evoked excitatory postsynaptic currents (EPSCs) mediated by AMPARs and NMDARs and inhibitory postsynaptic currents (IPSCs) mediated by GABA A receptors. We observed a large selective reduction ($45%) in AMPARmediated EPSCs in Nrx3 SS4+ neurons compared to WT or Nrx3 SS4-neurons ( Figure 1G ). We detected no change in NMDAR-mediated EPSCs or in IPSCs ( Figures 1H and 1I ). Paired-pulse ratios (PPRs) of NMDAR EPSCs were identical in WT, Nrx3
SS4+
, and Nrx3 SS4-neurons ( Figure S1F ). Together, these data suggest that SS4 alternative splicing selectively alters postsynaptic AMPAR responses without changing presynaptic neurotransmitter release or postsynaptic NMDAR responses.
SS4 Alternative Splicing of All Neurexins Controls Postsynaptic AMPARs
We next asked whether the decrease in AMPAR-mediated EPSCs in Nrx3 SS4+ neurons can be reversed by expression of different neurexins in an SS4-dependent manner. We superinfected WT, Nrx3 SS4+ , and Nrx3 SS4-neurons at DIV4-5 with lentiviruses expressing either control GFP or ''rescue'' neurexins and measured evoked AMPAR-mediated EPSCs at DIV14-16 ( Figure 2 of the AMPAR subunits GluA1 and GluA2. We fixed and permeabilized the GluA1-stained neurons and stained them for the intracellular presynaptic marker vGluT1 and the postsynaptic marker PSD95 ( Figure S2A ). Quantification of surface GluA1-and GluA2-containing puncta or of intracellular vGluT1-or PSD95-containing puncta did not reveal a difference in synapse density between WT, Nrx3 SS4+ , and Nrx3 SS4-neurons (Figures 3A, 3B, and S2B; for absolute values, see Figure S2C ). However, the size of postsynaptic GluA1-and GluA2-containing surface clusters was 40%-50% smaller in Nrx3 SS4+ neurons than in WT and Nrx3 SS4-neurons, whereas the size of PSD95-or vGluT1-containing clusters was not significantly altered (Figure 3B) . The decrease in GluA1 and GluA2 puncta size was uniformly distributed among synapses ( Figure 3C ). No effect on AMPAR intensity (i.e., the amount of AMPARs per area) was observed ( Figure S2B ).
To determine why the Nrx3 SS4+ genotype decreased postsynaptic AMPAR levels, we measured GluA1 internalization in cultured hippocampal neurons (Lin et al., 2000) . We incubated WT, Nrx3
SS4+
, and Nrx3 SS4-neurons briefly (5 min) with an antibody to the extracellular N terminus of GluA1, followed by a 15 min chase ( Figure S2D ). We then fixed the neurons without permeabilization, labeled them with an AlexaFluor488-tagged secondary antibody (green) to mark surface GluA1 receptors, permeabilized the neurons, and labeled them with a different secondary antibody that was AlexaFluor546 tagged (red) to detect internalized GluA1 receptors ( Figure 3D ). Strikingly, we found that GluA1 internalization was increased $60% in Nrx3 SS4+ neurons compared to WT and to Nrx3 neurons, which exhibited identical values ( Figure 3E ). Taken together, these data show that the constitutive inclusion of SS4 in Nrx3 decreases postsynaptic surface AMPARs and accelerates AMPAR endocytosis.
Presynaptic Membrane-Tethered Nrx3 Controls Postsynaptic AMPARs
To test whether Nrx3-SS4-acts pre-or postsynaptically to stabilize postsynaptic AMPARs, we sparsely transfected neurons. We then measured whether postsynaptically expressed Nrx3-SS4-could rescue the decrease in AMPAR responses in Nrx3 SS4+ neurons ( Figure 4A ).
We observed no difference between Nrx3 SS4+ neurons without or with postsynaptic ''rescue'' by Nrx3-SS4-, suggesting that postsynaptic Nrx3 cannot stabilize postsynaptic AMPAR levels.
To confirm this conclusion, we asked whether cre-recombinase-mediated postsynaptic conversion of Nrx3
SS4+
into Nrx3 SS4-rescues AMPAR levels in a neuron ( Figure 4B ). Again, we failed to observe rescue, suggesting that postsynaptic Nrx3 does not contribute to the regulation of postsynaptic AMPARs and arguing by default that Nrx3 must act by a presynaptic mechanism.
Does presynaptic Nrx3b-SS4-stabilize AMPARs via an intraor extracellular interaction? We addressed this question by testing a fusion protein composed of the extracellular Nrx3b sequences and the PDGF receptor transmembrane region ( Figure 4C) or GluA2 AMPARs (see Figure S2A for experimental protocol); GluA1-stained neurons were permeabilized and also stained for the excitatory synaptic makers PSD95 and vGluT1 (green, surface GluA1; red, PSD95; blue, vGluT1; scale bars, 5 mm). Figure S2D . Data are the means ± SEM of four independent experiments. Statistical analyses were performed by single-factor ANOVA (*p < 0.05; **p < 0.01; and ***p < 0.001).
However, we found that secreted Nrx3b-independent of the SS4 splice variant-was unable to rescue AMPAR EPSCs in Nrx3 SS4+ neurons, suggesting that membrane tethering of the Nrx3 extracellular sequences is essential ( Figure 4D ).
Nrx3-SS4 Alternative Splicing Controls AMPAR Responses in Vivo
Although cultured neurons allow a quantitative definition of synaptic parameters such as synaptic strength, cultured neurons lack some properties of neural networks, such as a defined cytoarchitecture or long-term plasticity. Moreover, differentiation between pre-and postsynaptic effects can be difficult in cultured neurons. To address these issues, we analyzed the effects of Nrx3-SS4 alternative splicing in presynaptic CA1 neurons of the hippocampus at synapses formed onto postsynaptic pyramidal neurons in the subiculum ( Figure 5A ). The subiculum is the major synaptic output for hippocampal CA1 neurons but additionally receives synapses from the entorhinal, perirhinal, and prefrontal cortex (O'Mara, 2005) . We decided to analyze the CA1 subiculum synapse because it is amenable to specifically presynaptic manipulations by stereotactic injection of viruses into the CA1 region (Xu et al., 2012) . This approach allowed us to record from uninfected subicular neurons receiving inputs from infected CA1 neurons and thus enabled us to selectively probe the effect of presynaptic alternative splicing of Nrx3 on postsynaptic AMPAR responses ( Figure 5A ).
We stereotactically injected the hippocampal CA1 region of WT or Nrx3 SS4+ mice at P21 with control or cre-recombinase expressing adeno-associated viruses (AAVs) and analyzed the mice at P35-42. EGFP expression documented that the CA1 region and dentate gyrus of the hippocampus, but not the subiculum or the CA3 region, were infected ( Figure 5A) ). We sectioned horizontal slices (300 mm) from the dorsal hippocampus of injected mice, stimulated CA1 axons with an extracellular electrode placed in the alveus/stratum oriens at the border of the CA1 pyramidal layer and the subiculum, and recorded from subicular pyramidal neurons ( Figure 5A ). 
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n.s. We first measured the AMPAR-to-NMDAR ratio. Figures 1G and 1H ).
To confirm that presynaptic Nrx3-SS4 alternative splicing regulates postsynaptic AMPARs, we measured AMPAR-mediated input-output curves. The subiculum contains two types of pyramidal neurons, regular and burst firing neurons. These neurons differ in firing patterns ( Figure S3A ) and express different forms of LTP but receive similar inputs and exhibit comparable basal transmission properties (Taube, 1993; Staff et al., 2000; Menendez de la Prida et al., 2003; Wozny et al., 2008 5E ). We also measured paired-pulse ratios in regular and burst-firing subicular neurons to identify possible presynaptic changes but detected none ( Figures 5D, 5F , S3B, and S3C). Viewed together, these data indicate that, in adult mice in vivo, constitutive inclusion of SS4 in presynaptic Nrx3 mRNAs causes a selective and highly significant decrease in postsynaptic AMPAR responses that can be reversed by removal of the SS4 exon.
Constitutive Presynaptic Nrx3-SS4+ Expression Impairs Postsynaptic LTP
In regular firing neurons of the subiculum, the threshold for LTP induction is high, and LTP is mediated by a postsynaptic, NMDAR-dependent mechanism similar to classical LTP at Schaffer-collateral CA1-region synapses of the hippocampus (Wozny et al., 2008) . By contrast, in burst-firing neurons, the LTP induction threshold is low and LTP is mediated by a presynaptic mechanism that increases the probability of glutamate release. Although the mechanisms of LTP differ between the two types of neurons, LTP induction appears to require Ca 2+ influx via NMDA receptors in both ( Figure S4 ; Wozny et al., 2008) . We induced LTP in acute slices from WT, Nrx3 SS4+ -CA1 Ctrl , and Nrx3
SS4+ -CA1
Cre mice by four 100 Hz tetani separated by 10 s and measured LTP induction in regular and burst-firing neurons. We observed a marked reduction ($70%) of LTP in regular firing neurons from Nrx3 SS4+ -CA1 Ctrl mice compared to WT and Nrx3
Cre mice ( Figures 6A and 6B ). We detected no decrease in paired-pulse ratio after LTP induction in regular firing neurons in any genotype, in agreement with the finding that LTP in these neurons is postsynaptic ( Figures 6B, S4B , and S4C). In contrast to regular firing neurons, we observed no significant difference in LTP in burst-firing neurons in slices from Nrx3
, and WT mice ( Figures 6C  and 6D) . Consistent with the previously described presynaptic mechanism of LTP in burst-firing neurons (Wozny et al., 2008) , we found that LTP induction in burst-firing neurons caused a significant decrease in the paired-pulse ratio in all three genotypes ( Figure 6D ). Taken together, these data demonstrate that constitutive presynaptic expression of Nrx3-SS4+ impairs postsynaptic LTP in regular firing neurons.
Constitutive Nrx3-SS4+ Expression Decreases Postsynaptic LRRTM2 Levels The reduction of AMPAR-mediated basal synaptic transmission and the block of LTP by presynaptic Nrx3-SS4+ suggests that presynaptic Nrx3-SS4-may interact with one or several postsynaptic ligand(s) that control postsynaptic AMPAR levels. Two neurexin ligands are linked to AMPARs, neuroligins (Chubykin et al., 2007; Etherton et al., 2011), and LRRTMs (de Wit et al., 2009; Schwenk et al., 2012) . Moreover, reduction of neuroligin and LRRTM levels in postsynaptic neurons specifically impaired AMPAR-mediated transmission in vivo (Soler-Llavina et al., 2011) . Furthermore, we recently found that LRRTM knockdown in vivo severely impairs NMDAR-mediated LTP (Soler-Llavina et al., 2013 ). Thus, we tested whether the postsynaptic levels of LRRTM2 (the major LRRTM isoform in the hippocampus) and neuroligin-1 (the major neuroligin isoform of excitatory synapses) were altered by Nrx3-SS4+ expression ( Figures 7A-7C and S5). Strikingly, we found that the apparent postsynaptic surface levels of LRRTM2 were decreased $45%, whereas neuroligin-1 did not exhibit a significant change. These data support the notion that presynaptic Nrx3-SS4-acts to enable postsynaptic AMPAR retention by activating LRRTM2 and possibly other ligands.
DISCUSSION
Alternative splicing of neurexins is highly regulated and controls neurexin binding to multiple ligands, but its biological significance is unknown. Using a genetic strategy, we here addressed this question. We focused on alternative splicing of Nrx3 at SS4, which is particularly strongly regulated ( Figure 1A ) and controls Nrx3 binding to neuroligins, LRRTMs, cerebellins, dystroglycan, and CIRL/latrophilin (Ichtchenko et al., 1995; Sugita et al., 2001; Ko et al., 2009; Siddiqui et al., 2010; Uemura et al., 2010; Boucard et al., 2012) . Alternative splicing of Nrx3 at SS4 involves inclusion or exclusion of a single exon that exhibits an unusual purine-rich splice acceptor sequence (Tabuchi and Sü dhof, 2002) . We converted this noncanonical splice-acceptor sequence into a canonical splice-acceptor sequence to render the exon constitutively ''spliced in'' and flanked the SS4 exon with loxP sites to allow the exon to be constitutively ''spliced out'' by cre-recombinase ( Figures 1B and Figure 1C ). Different from traditional approaches, such as conditional knockoutand-rescue methods, this genetic approach does not alter expression of the endogenous gene and does not interfere with other alternative splicing events. The genetic approach that we developed here enabled us to examine the role of neurexin alternative splicing in vivo and may be generally applicable for studies of the physiological significance of alternative splicing.
Using the genetic tool that we generated, we demonstrate that alternative splicing of presynaptic Nrx3 at SS4 trans-synaptically regulates the strength of excitatory synapses by controlling postsynaptic AMPAR levels. Thus, we describe a mechanism of trans-synaptic control of postsynaptic receptors by a presynaptic ligand. Although neurexin alternative splicing has been (Wozny et al., 2008) , LTP in burst-firing neurons causes a change in paired-pulse ratio, suggesting that it is presynaptic (D), whereas LTP in regular firing neurons does not cause a change in paired-pulse ratio, consistent with a postsynaptic localization (B). Data shown are means ± SEM; numbers of neurons/mice examined are shown in the graphs. Statistical analyses were performed by single-factor ANOVA (*p < 0.05; **p < 0.01; and ***p < 0.001). See also Figure S4 .
extensively studied in vitro Resnick et al., 2008; Iijima et al., 2011) , its significance was unknown. Our data thus show that alternative splicing of neurexins is indeed physiologically important and, at least for SS4, has a major effect on synaptic transmission. In Nrx3-SS4+ neurons, the number of synapses was unchanged, as evidenced by the lack of change in synapse density, mEPSC frequency, and NMDAR-mediated EPSCs. However, the synaptic levels of AMPARs were decreased, as evidenced by decreased GluA1 and GluA2 puncta sizes, decreased mEPSC amplitudes, decreased evoked AMPAR-mediated EPSCs, and increased AMPAR endocytosis (Figures 1 and 3) . Viewed together, these data suggest that presynaptic Nrx3-SS4-, but not Nrx3-SS4+, produces anchoring sites for postsynaptic AMPARs ( Figure 7D ). In controlling postsynaptic AMPAR levels, neurexins act strictly presynaptically, as shown by the specifically pre-and postsynaptic manipulations that we performed in vitro (Figure 4 ) and in vivo (Figures 5 and 6 ). Thus, our results reveal a pathway of trans-synaptic signaling and offer a potential explanation for the observation that the properties of a synapse are determined by a trans-synaptic interaction between pre-and postsynaptic elements (Reyes et al., 1998; Koester and Johnston, 2005) .
Our data also suggest a mechanism by which alternative splicing of presynaptic neurexins may control postsynaptic AMPAR content. Presynaptic membrane-tethered Nrx3 was sufficient for stabilizing postsynaptic AMPARs, whereas secreted Nrx3 was inactive (Figure 4) . Thus, presynaptic neurexins likely connect to a postsynaptic ligand. Neurexins interact with several postsynaptic ligands in a largely competitive manner, most importantly with neuroligins and LRRTMs ( Figure 7D ). These interactions form a dynamic interaction network in which the postsynaptic neurexin ligands in turn interact with other ligands (e.g., see Lee et al., 2013) . The relative concentrations and alternative splicing of neurexins and their ligands determine the state of the network. This dynamic interaction network results in a binding equilibrium whereby not a single neurexin binding reaction can explain all of the observed actions of neurexins, but the overall state of the network determines the properties of a synapse. (Etherton et al., 2011; Soler-Llavina et al., 2011; Schwenk et al., 2012) , possibly via their binding to PSD95, which in turn binds to the C-terminal sequences of TARPs that form a tight complex with AMPARs (Schnell et al., 2012) . The data in (A)-(C) suggest that the Nrx3-LRRTM interaction is most important for controlling postsynaptic AMPAR levels, but different isoforms of neuroligin differentially interact with the two Nrx3-SS4 splice variants, and thus a major contribution of interactions of neurexins with neuroligins or other ligands in controlling postsynaptic AMPARs cannot be ruled out.
Among neurexin ligands, both neuroligins and LRRTMs regulate AMPARs (Chubykin et al., 2007; de Wit et al., 2009; Etherton et al., 2011; Soler-Llavina et al., 2011; Schnell et al., 2012) . Strikingly, we found that postsynaptic LRRTM2 is decreased in Nrx3-SS4+ neurons (Figures 7A-7C ). LRRTM2 binds only to SS4-neurexins (Ko et al., 2009; Siddiqui et al., 2010) , suggesting that neurexins control AMPARs by binding to LRRTMs, although neuroligins may also contribute because they differentially interact with both SS4+ and SS4-neurexins (Ichtchenko et al., 1995; Boucard et al., 2005; Chih et al., 2006) . Given the importance of SS4 in regulating ligand interactions of neurexins, it seems likely that SS4 is a central regulator of the neurexin-based dynamic protein-interaction network. Changing alternative splicing of Nrx3 at SS4 may shift this network without altering other neurexin functions, thereby producing the AMPAR phenotype that we observed ( Figure 7D ).
Finally, our study unexpectedly identifies a presynaptic molecular event that is required as a permissive signal for normal postsynaptic NMDAR-dependent LTP, indicating that the presynaptic terminal can ''gate'' postsynaptic LTP. Specifically, we show that alternative splicing of SS4 in Nrx3 not only regulates constitutive AMPAR trafficking, but also enables activity-dependent recruitment of AMPARs during LTP induction ( Figure 6 ). The decades-old debate of whether NMDAR-dependent LTP is pre-or postsynaptically induced was resolved when LTP was found to be induced by recruitment of AMPARs to synapses (Kerchner and Nicoll, 2008) . Although LTP is clearly postsynaptically induced, our results show that LTP induction nevertheless requires presynaptic ''permission,'' thereby rendering LTP under control of both pre-and postsynaptic neurons (Figure 6 ). This permission is likely mediated by Nrx3 binding to LRRTMs, as LRRTM knockdowns also produce a decrease in LTP (Soler-Llavina et al., 2013) . Thus, a presynaptic mechanism surprisingly controls postsynaptically induced long-term synaptic plasticity.
We would like to emphasize that the selective phenotype that we observed in Nrx3-SS4+ neurons does not mean that regulating AMPAR levels is the only function of Nrx3 or even of Nrx3-SS4 alternative splicing. It seems likely that Nrx1, Nrx2, and Nrx3 have overlapping functions based on our rescue experiments ( Figure 2 ) and previous studies (Missler et al., 2003) . Presumably, the phenotype produced by manipulating only Nrx3 reflects neurexin functions that are incompletely compensated for by the other two neurexins, possibly because the other neurexins are not coexpressed at sufficiently high levels in the affected synapses. It seems likely that the AMPAR phenotype will be even more severe in mice carrying SS4 mutations in multiple neurexins. Moreover, alternative splicing of neurexins at SS4 may also mediate trans-synaptic control of other synaptic receptors.
How do the present results then relate to previous genetic studies on a-neurexin triple KO mice, which reported changes in the presynaptic release machinery and in postsynaptic NMDARs instead of AMPARs (Kattenstroth et al., 2004; Missler et al., 2003) ? It should be noted that there is neither overlap in phenotypes nor overlap in genetic manipulations between the previous and current studies. In the previous studies, all a-neurexins were deleted but b-neurexins were normally expressed, whereas in the present study, alternative splicing of both Nrx3a and Nrx3b at SS4 was selectively altered with continued unaltered expression of all a-and b-neurexins. The fact that these disparate manipulations have distinct effects supports the notion that neurexins perform multiple independent functions via different domains that are regulated by distinct events of alternative splicing. Such functional diversity is consistent with the many ligands observed for neurexins, which form a complex dynamic interaction network, and emphasizes the critical role that neurexins play in synaptic transmission.
EXPERIMENTAL PROCEDURES
In all experiments, the experimenter was blinded to the sample genotype. All plasmids are available upon request, and the mice described here were deposited in Jackson Labs for distribution.
Mouse Generation and Husbandry
Nrx3
SS4+ mutant mice were generated by homologous recombination (Figure 1B) , and Nrx3 SS4-mice were produced by cre-recombinase mediated deletion of exon 20 in the germline of Nrx3 SS4+ mutant mice (Kaeser et al., 2011) . All mouse work was approved by animal use committees at Stanford University (for details, see the Extended Experimental Procedures).
mRNA Measurements mRNA measurements were performed using quantitative RT-PCR with b-actin as the endogenous internal control. For primer sequences and assay validations, see the Extended Experimental Procedures.
Virus Preparations
All lentiviruses were constructed as described using the synapsin promoter to drive expression (Kaeser et al., 2011) . AAVs were constructed as described using a CMV-actin-globin promoter. For details, see the Extended Experimental Procedures.
Hippocampal Neurons
Hippocampal neurons were cultured from newborn WT and Nrx3 SS4+ mice (Kaeser et al., 2011) , infected on DIV4-5 with lentiviruses, and analyzed at DIV13-16. Rescue experiments were performed by concurrent superinfection of neurons with rescue viruses. Transfections used the calcium phosphate method.
AMPAR Imaging Experiments
AMPAR imaging experiments were performed and quantified as described (Aoto et al., 2008; Lin et al., 2000) . For details, see the Extended Experimental Procedures.
Stereotactic Injections
Stereotactic injections of AAVs were performed as described (Xu et al., 2012) . Efficiency and localization of AAV expression were confirmed by histochemistry of nuclear GFP encoded by the expressed inactive and active GFP-crerecombinase fusion proteins.
Electrophysiology
Recordings from cultured neurons and acute slice electrophysiology were performed essentially as described (Kaeser et al., 2011; Etherton et al., 2011; Wozny et al., 2008 
